{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:25:29Z","timestamp":1794270329810,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:00:00Z","timestamp":1794268800000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01528-3","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T18:04:53Z","timestamp":1784484293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Eman A.","family":"Toraih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Aiash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"1528_CR1","unstructured":"Organization W. H. World Health Statistics 2025. WHO. (https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o)."},{"key":"1528_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/17476348.2025.2515992","volume":"19","author":"N Leite Barbosa","year":"2025","unstructured":"Leite Barbosa, N. et al. Prevalence and characteristics of respiratory and cardiovascular sequelae in post-COVID-19 syndromes: a scoping review. Expert Rev. Respir. Med. 19, 935\u2013953 (2025). (In eng).","journal-title":"Expert Rev. Respir. Med."},{"key":"1528_CR3","doi-asserted-by":"publisher","unstructured":"Denegri, A. et al. Cardiovascular complications of COVID-19 disease: a narrative review. Diseases https:\/\/doi.org\/10.3390\/diseases13080252 (2025).","DOI":"10.3390\/diseases13080252"},{"key":"1528_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101619","volume":"53","author":"W Wang","year":"2022","unstructured":"Wang, W., Wang, C. Y., Wang, S. I. & Wei, J. C. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine 53, 101619 (2022). (In eng).","journal-title":"EClinicalMedicine"},{"key":"1528_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/23969873231190432","volume":"8","author":"M Zuin","year":"2023","unstructured":"Zuin, M., Mazzitelli, M., Rigatelli, G., Bilato, C. & Cattelan, A. M. Risk of ischemic stroke in patients recovered from COVID-19 infection: a systematic review and meta-analysis. Eur. Stroke J. 8, 915\u2013922 (2023). (In eng).","journal-title":"Eur. Stroke J."},{"key":"1528_CR6","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","volume":"5","author":"D Lindner","year":"2020","unstructured":"Lindner, D. et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 5, 1281\u20131285 (2020). (In eng).","journal-title":"JAMA Cardiol."},{"key":"1528_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93, 250\u2013256 (2021). (In eng).","journal-title":"J. Med. Virol."},{"key":"1528_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120\u2013128 (2020). (In eng).","journal-title":"N. Engl. J. Med."},{"key":"1528_CR9","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N. Engl. J. Med. 385, 1761\u20131773 (2021). (In eng).","journal-title":"N. Engl. J. Med."},{"key":"1528_CR10","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020). (In eng).","journal-title":"N. Engl. J. Med."},{"key":"1528_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster, M. E. et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. J. Am. Med. Assoc. 327, 331\u2013340 (2022). (In eng).","journal-title":"J. Am. Med. Assoc."},{"key":"1528_CR12","doi-asserted-by":"publisher","unstructured":"Das, B. B., Moskowitz, W. B., Taylor, M. B. & Palmer, A. Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far? Children (Basel) https:\/\/doi.org\/10.3390\/children8070607 (2021).","DOI":"10.3390\/children8070607"},{"key":"1528_CR13","doi-asserted-by":"publisher","unstructured":"Marshall, M. et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics https:\/\/doi.org\/10.1542\/peds.2021-052478 (2021).","DOI":"10.1542\/peds.2021-052478"},{"key":"1528_CR14","doi-asserted-by":"publisher","unstructured":"Karimi, R., Norozirad, M., Esmaeili, F., Mansourian, M. & Marateb, H. R. COVID-19 Vaccination and cardiovascular events: a systematic review and Bayesian multivariate meta-analysis of preventive benefits and risks. Int. J. Prev. Med. https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_260_24 (2025).","DOI":"10.4103\/ijpvm.ijpvm_260_24"},{"key":"1528_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-2600(24)00179-6","volume":"12","author":"MMI Mesl\u00e9","year":"2024","unstructured":"Mesl\u00e9, M. M. I. et al. Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study. Lancet Respir. Med. 12, 714\u2013727 (2024). (In eng).","journal-title":"Lancet Respir. Med."},{"key":"1528_CR16","doi-asserted-by":"publisher","unstructured":"Tobaiqy, M., MacLure, K., Elkout, H. & Stewart, D. Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database. Vaccines (Basel) https:\/\/doi.org\/10.3390\/vaccines9111326 (2021).","DOI":"10.3390\/vaccines9111326"},{"key":"1528_CR17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","volume":"43","author":"B Raman","year":"2022","unstructured":"Raman, B., Bluemke, D. A., L\u00fcscher, T. F. & Neubauer, S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43, 1157\u20131172 (2022). (In eng).","journal-title":"Eur. Heart J."},{"key":"1528_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10456-023-09885-6","volume":"26","author":"T Kuchler","year":"2023","unstructured":"Kuchler, T. et al. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation. Angiogenesis 26, 547\u2013563 (2023). (In eng).","journal-title":"Angiogenesis"},{"key":"1528_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1268571","volume":"11","author":"RH Mostafa","year":"2024","unstructured":"Mostafa, R. H. & Moustafa, A. Beyond acute infection: molecular mechanisms underpinning cardiovascular complications in long COVID. Front. Cardiovasc. Med. 11, 1268571 (2024). (In eng).","journal-title":"Front. Cardiovasc. Med."},{"key":"1528_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937\u2013952 (2004). (In eng).","journal-title":"Lancet"},{"key":"1528_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259\u2013264 (2021). (In eng).","journal-title":"Nature"},{"key":"1528_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583\u2013590 (2022). (In eng).","journal-title":"Nat. Med."},{"key":"1528_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/heartjnl-2022-321492","volume":"109","author":"Z Raisi-Estabragh","year":"2022","unstructured":"Raisi-Estabragh, Z. et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart 109, 119\u2013126 (2022). (In eng).","journal-title":"Heart"},{"key":"1528_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101070","volume":"3","author":"M Aljadah","year":"2024","unstructured":"Aljadah, M. et al. Clinical implications of COVID-19-related endothelial dysfunction. JACC Adv. 3, 101070 (2024). (In eng).","journal-title":"JACC Adv."},{"key":"1528_CR25","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1001\/jama.2025.2033","volume":"333","author":"F Khan","year":"2025","unstructured":"Khan, F. et al. Long-term risk of stroke after transient ischemic attack or minor stroke: a systematic review and meta-analysis. J. Am. Med. Assoc. 333, 1508\u20131519 (2025). (In eng).","journal-title":"J. Am. Med. Assoc."},{"key":"1528_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","volume":"28","author":"M Patone","year":"2022","unstructured":"Patone, M. et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 28, 410\u2013422 (2022). (In eng).","journal-title":"Nat. Med."},{"key":"1528_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2020.107300","volume":"50","author":"MK Halushka","year":"2021","unstructured":"Halushka, M. K. & Vander Heide, R. S. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc. Pathol. 50, 107300 (2021). (In eng).","journal-title":"Cardiovasc. Pathol."},{"key":"1528_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021). (In eng).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1528_CR29","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","volume":"147","author":"LM Yonker","year":"2023","unstructured":"Yonker, L. M. et al. Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation 147, 867\u2013876 (2023). (In eng).","journal-title":"Circulation"},{"key":"1528_CR30","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMc2205357","volume":"386","author":"A Wohl","year":"2022","unstructured":"Wohl, A. & Leibowitz, R. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. N. Engl. J. Med. 386, 2441 (2022). (In eng).","journal-title":"N. Engl. J. Med."},{"key":"1528_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0829","volume":"374","author":"RR Goel","year":"2021","unstructured":"Goel, R. R. et al. mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science 374, abm0829 (2021). (In eng).","journal-title":"Science"},{"key":"1528_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\u2013113 (2021).","journal-title":"Nature"},{"key":"1528_CR33","doi-asserted-by":"crossref","unstructured":"Kawai, K., Muhere, C. F., Lemos, E. V. & Francis, J. M. Viral Infections and risk of cardiovascular disease: systematic review and meta-analysis. J. Am. Heart Assoc. 14, e042670 (2025).","DOI":"10.1161\/JAHA.125.042670"},{"key":"1528_CR34","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2013.279206","volume":"310","author":"JA Udell","year":"2013","unstructured":"Udell, J. A. et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. J. Am. Med. Assoc. 310, 1711\u20131720 (2013). (In eng).","journal-title":"J. Am. Med. Assoc."},{"key":"1528_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jtha.2023.09.022","volume":"22","author":"A Mroueh","year":"2024","unstructured":"Mroueh, A. et al. COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines\/SGLT2 prooxidant pathway. J. Thrombosis Haemost. 22, 286\u2013299 (2024).","journal-title":"J. Thrombosis Haemost."},{"key":"1528_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1517933","volume":"16","author":"N \u0106wilichowska-Pu\u015blecka","year":"2025","unstructured":"\u0106wilichowska-Pu\u015blecka, N. et al. Understanding the long-term interplay of SARS-CoV-2 immune and inflammatory responses with proteases in COVID-19 recovery: a longitudinal study. Front. Immunol. 16, 1517933 (2025). (In eng).","journal-title":"Front. Immunol."},{"key":"1528_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","volume":"11","author":"C Gebhard","year":"2020","unstructured":"Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R. & Klein, S. L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex. Differ. 11, 29 (2020). (In eng).","journal-title":"Biol. Sex. Differ."},{"key":"1528_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1210\/er.2007-0001","volume":"28","author":"RH Straub","year":"2007","unstructured":"Straub, R. H. The complex role of estrogens in inflammation. Endocr. Rev. 28, 521\u2013574 (2007). (In eng).","journal-title":"Endocr. Rev."},{"key":"1528_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fimmu.2018.00794","volume":"9","author":"MR Gubbels Bupp","year":"2018","unstructured":"Gubbels Bupp, M. R. & Jorgensen, T. N. Androgen-induced immunosuppression. Front Immunol. 9, 794 (2018). (In eng).","journal-title":"Front Immunol."},{"key":"1528_CR40","doi-asserted-by":"publisher","first-page":"12477","DOI":"10.1073\/pnas.1805268115","volume":"115","author":"AL Fink","year":"2018","unstructured":"Fink, A. L., Engle, K., Ursin, R. L., Tang, W. Y. & Klein, S. L. Biological sex affects vaccine efficacy and protection against influenza in mice. Proc. Natl. Acad. Sci. USA 115, 12477\u201312482 (2018). (In eng).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1528_CR41","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016). (In eng).","journal-title":"Nat. Rev. Immunol."},{"key":"1528_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa, S. Immortal time bias in pharmaco-epidemiology. Am. J. Epidemiol. 167, 492\u2013499 (2008). (In eng).","journal-title":"Am. J. Epidemiol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01528-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01528-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:20:29Z","timestamp":1794270029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01528-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01528-3","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.T. was an investigator in the phase 3 trial of the BNT162b2 COVID-19 vaccine and has participated on data safety monitoring boards, independent data monitoring committees, and in consultative and advisory capacities for several industry sponsors of COVID-19 vaccines. He has been compensated for his time. The remaining authors (E.A.T., D.B., M.H.H., and H.A.) declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"210"}}